MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system

BACKGROUND: Primary diffuse large B-cell lymphoma of the central nervous system (PCNS-DLBCL) is a distinct clinicopathological entity with a poor prognosis. Concurrent MYC and BCL2 overexpression predicts inferior prognosis in systemic DLBCLs. However, the prognostic significance of MYC and BCL2 in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Kim, Sehui, Nam, Soo Jeong, Kwon, Dohee, Kim, Hannah, Lee, Eunyoung, Kim, Tae Min, Heo, Dae Seog, Park, Sung Hye, Kim, Chul Woo, Jeon, Yoon Kyung
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4903010/
https://ncbi.nlm.nih.gov/pubmed/27286976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2397-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares